0001447362-23-000071.txt : 20230508 0001447362-23-000071.hdr.sgml : 20230508 20230508162621 ACCESSION NUMBER: 0001447362-23-000071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230504 FILED AS OF DATE: 20230508 DATE AS OF CHANGE: 20230508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRADBURY DANIEL CENTRAL INDEX KEY: 0001236397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38984 FILM NUMBER: 23898168 MAIL ADDRESS: STREET 1: BIOBRIT, LLC STREET 2: 2223 AVENIDA DE LA PLAYA, SUITE 108 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC CENTRAL INDEX KEY: 0001447362 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770701774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 S FRIENDSWOOD DRIVE STREET 2: SUITE 401 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 BUSINESS PHONE: 866-788-9007 MAIL ADDRESS: STREET 1: 505 S FRIENDSWOOD DRIVE STREET 2: SUITE 401 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 4 1 wf-form4_168357756885543.xml FORM 4 X0407 4 2023-05-04 0 0001447362 CASTLE BIOSCIENCES INC CSTL 0001236397 BRADBURY DANIEL C/O CASTLE BIOSCIENCES, INC. 505 S. FRIENDSWOOD DRIVE, SUITE 401 FRIENDSWOOD TX 77546 1 0 0 0 0 Common Stock 2023-05-04 4 S 0 3400 21.289 D 151139 I By LLC Common Stock 2023-05-04 4 S 0 1134 21.289 D 81646 I By Daniel Bradbury Irrecovable Descendant's Trust Common Stock 2023-05-04 4 S 0 1133 21.289 D 81672 I By Annette Bradbury Irrecovable Descendant's Trust Common Stock 2023-05-04 4 S 0 7185 21.879 D 143954 I By LLC Common Stock 2023-05-04 4 S 0 2395 21.879 D 79251 I By Daniel Bradbury Irrecovable Descendant's Trust Common Stock 2023-05-04 4 S 0 2396 21.879 D 79276 I By Annette Bradbury Irrecovable Descendant's Trust Common Stock 2023-05-05 4 S 0 2039 21.117 D 141915 I By LLC Common Stock 2023-05-05 4 S 0 679 21.117 D 78572 I By Daniel Bradbury Irrecovable Descendant's Trust Common Stock 2023-05-05 4 S 0 680 21.117 D 78596 I By Annette Bradbury Irrecovable Descendant's Trust Common Stock 2023-05-05 4 S 0 2376 21.804 D 139539 I By LLC Common Stock 2023-05-05 4 S 0 792 21.804 D 77780 I By Daniel Bradbury Irrecovable Descendant's Trust Common Stock 2023-05-05 4 S 0 791 21.804 D 77805 I By Annette Bradbury Irrecovable Descendant's Trust Common Stock 830 D The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022. This transaction was executed in multiple trades at prices ranging from $20.640 to $21.635, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. This transaction was executed in multiple trades at prices ranging from $21.640 to $22.310, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $20.570 to $21.565, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $21.570 to $22.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Greg Acosta, Attorney-in-fact 2023-05-08